Ballatori N, Clarkson T W
Fundam Appl Toxicol. 1985 Oct;5(5):816-31. doi: 10.1016/0272-0590(85)90165-4.
As bile is the main route of elimination of many metals, a large number of studies have been directed toward the characterization of the hepatobiliary transport of both endogenous and exogenous metals. Although some progress has been made, we still know little of the basic mechanisms involved in the hepatocellular uptake of metals, in their intracellular translocation and metabolism, or in their transport into bile. Our recent studies have focused on the last step in the hepatobiliary transport of mercury, namely, the secretion of the metal from liver cells into bile. The rate of secretion of methyl and inorganic mercury into bile was low in suckling rats and rapidly increased to adult rates soon after weaning. These changes closely followed similar developmental changes in the biliary secretion of reduced glutathione (GSH). When GSH secretion into bile was completely inhibited, without changing hepatic levels of GSH or mercury, mercury secretion was also completely blocked. Mercury secretion paralleled individual and sex-related differences in GSH secretion. At the same time, the secretion of mercury was independent of bile flow, of the thiol and mercury concentration gradients between bile and liver cells, and of those between bile and plasma. Our results, therefore, indicate a close coupling between the secretion of mercury and that of GSH. These in vivo findings, along with in vitro studies by others in vesicles isolated from the canalicular membrane of the liver cell, indicate a carrier-mediated transport system for GSH, but the nature of the linkage of this transport system with mercury secretion is not yet fully established. Our data and those in the literature are consistent with the involvement of at least two steps in the movement of mercury from liver cells to bile--the formation of a mercury-glutathione complex in the liver cell, followed by the secretion of this complex through a process closely linked to GSH secretion. The identification of GSH as an endogenous complexing agent in the transport of metals between tissues and body fluids now permits the design of therapeutic strategies aimed at exploiting this transport vehicle to effect the removal of metals via physiological routes of excretion. The present discussion considers the role of GSH in the hepatobiliary transport of metals. In doing so, a brief review is given of current understanding of hepatic GSH metabolism and transport.
由于胆汁是许多金属排出体外的主要途径,大量研究致力于对内源性和外源性金属的肝胆转运特性进行表征。尽管已取得一些进展,但我们对金属在肝细胞摄取、细胞内转运与代谢以及向胆汁中转运所涉及的基本机制仍知之甚少。我们最近的研究聚焦于汞在肝胆转运的最后一步,即金属从肝细胞分泌到胆汁中。哺乳期大鼠甲基汞和无机汞向胆汁中的分泌速率较低,断奶后很快迅速升至成年水平。这些变化与还原型谷胱甘肽(GSH)胆汁分泌的类似发育变化密切相关。当胆汁中GSH分泌被完全抑制时,在不改变肝脏中GSH或汞水平的情况下,汞分泌也被完全阻断。汞分泌与GSH分泌的个体及性别差异平行。同时,汞的分泌与胆汁流量、胆汁与肝细胞之间的硫醇和汞浓度梯度以及胆汁与血浆之间的浓度梯度无关。因此,我们的结果表明汞分泌与GSH分泌之间存在紧密关联。这些体内研究结果,连同其他人对从肝细胞胆小管膜分离的囊泡进行的体外研究,表明存在一种GSH载体介导的转运系统,但该转运系统与汞分泌的联系性质尚未完全明确。我们的数据以及文献中的数据与汞从肝细胞向胆汁移动过程中至少涉及两个步骤一致——在肝细胞中形成汞 - 谷胱甘肽复合物,随后通过与GSH分泌紧密相关的过程分泌该复合物。GSH作为组织与体液之间金属转运中的内源性络合剂的鉴定,现在允许设计旨在利用这种转运载体通过生理排泄途径实现金属清除的治疗策略。本讨论考虑了GSH在金属肝胆转运中的作用。在此过程中,简要回顾了目前对肝脏GSH代谢和转运的理解。